Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

Officials from the Drugs Control Administration (DCA) carried out raids on multiple pharmaceutical dealers in Koti, Hyderabad and uncovered counterfeit stocks of the cholesterol-lowering medications Rosuvas F 20 and Rosuvas F 10.

These drugs are prescribed to lower cholesterol and triglyceride levels and prevent heart-related ailments. The spurious drugs were being circulated in the open market under the guise of legitimate products manufactured by Sun Pharmaceutical Industries Limited.

During the inspections on Thursday, DCA’s special enforcement team raided two outlets, Ganga Pharma Distributors and Sri Nandini Pharma, and seized fake batches of the medicine, both falsely labelled as being manufactured in December 2024 and set to expire in May 2027. The counterfeit packaging claimed Sun Pharma’s Sikkim unit as the manufacturing site, said a release. The estimated value of the seized counterfeit medicines is ₹3 lakh.

Upon verification, Sun Pharmaceutical Industries Limited confirmed to the authorities that the seized stocks were not genuine and had not been produced by their company. Officials stated that a detailed investigation is underway to trace the entire supply chain of the counterfeit products and that legal action will be initiated against all those found responsible.

Source: The Hindu

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit